申请人:Hubschwerlen Christian
公开号:US20100222302A1
公开(公告)日:2010-09-02
The invention relates to novel chimeric antibiotics of formula I
wherein
R
1
is CH
2
NHCOR
5
, heteroarylmethyl, heteroaryloxymethyl or heteroarylaminomethyl;
R
2
is H, OH, OSO
3
H, OPO
3
H
2
, OCH
2
OPO
3
H
2
, OCOCH
2
CH
2
COOH, OCOR
6
;
R
3
is H or halogen;
R
4
is (C
1
-C
3
)alkyl, (C
1
-C
3
)haloalkyl or cycloalkyl;
R
5
is alkyl or haloalkyl; and
R
6
is the residue of a naturally occurring amino acid or of dimethylaminoglycine.
These chimeric compounds are useful in the manufacture of medicaments for the treatment of infections (e.g. bacterial infections).
该发明涉及一种新型嵌合抗生素,其化学式为I,其中R1为CH2NHCOR5,杂环烷基甲基,杂环氧甲基或杂环氨基甲基;R2为H,OH,OSO3H,OPO3H2,OCH2OPO3H2,OCOCH2CH2COOH,OCOR6;R3为H或卤素;R4为(C1-C3)烷基,(C1-C3)卤代烷基或环烷基;R5为烷基或卤代烷基;R6为天然氨基酸残基或二甲氨基甘氨酸残基。这些嵌合化合物在制造治疗感染(例如细菌感染)的药物中非常有用。